ArticlePostdoc journal : a journal of postdoctoral research and postdoctoral affairs2017
Bacterial plasmid addiction systems and their implications for antibiotic drug development.
Article in Postdoc journal : a journal of postdoctoral research and postdoctoral affairs, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 26 citations in OpenAlex.
- Effects of phage-based treatments against an OXA-48-producing Klebsiella pneumoniae isolate in simulated human gut microbiomes.BMC microbiology · 2026Article
- Dual bacteriocin and extracellular vesicle-mediated inhibition ofApplied and environmental microbiology · 2024Article
- Prokaryotic Expression and Functional Verification of Antimicrobial Peptide LRInternational journal of molecular sciences · 2024Article
- Decoding the enigma: unveiling the transmission characteristics of waterfowl-associatedFrontiers in microbiology · 2024Article
- Characterization of plasmids carrying blaScientific reports · 2023Article
- Co-Harboring of Beta-Lactamases andAntibiotics (Basel, Switzerland) · 2023Article
- The balance between antibiotic resistance and fitness/virulence inFrontiers in microbiology · 2023Review
- Modeling endonuclease colicin-like bacteriocin operons as 'genetic arms' in plasmid-genome conflicts.Molecular genetics and genomics : MGG · 2022Article
- Decreasing the abundance of tetracycline-resistantVeterinary and animal science · 2022Article
- Transcriptional expression of secondary resistance genes ccdB and repA2 is enhanced in presence of cephalosporin and carbapenem in Escherichia coli.BMC microbiology · 2021Article
- Antibiotic resistance plasmid composition and architecture in Escherichia coli isolates from meat.Scientific reports · 2021Article
- The Cysteine Protease MaOC1, a Prokaryotic Caspase Homolog, Cleaves the Antitoxin of a Type II Toxin-Antitoxin System.Frontiers in microbiology · 2021Article
- Molecular epidemiology of carbapenem-resistance plasmids using publicly available sequences.Genome · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
Bacteria frequently carry mobile genetic elements capable of being passed to other bacterial cells. An example of this is the transfer of plasmids (small, circular DNA molecules) that often contain antibiotic resistance genes from one bacterium to another. Plasmids have evolved mechanisms to ensure their survival through generations by employing plasmids segregation and replication machinery and plasmid addiction systems. Plasmid addiction systems utilize a post-segregational killing of cells that have not received a plasmid. In this review, the types of plasmid addiction systems are described as well as their prevalence in antibiotic resistant bacteria. Lastly, the possibility of targeting these plasmid addiction systems for the treatment of antibiotic resistant bacterial infections is explored.
Indexed as
Identifiers
28781980PMC5542005W2618236612What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.